Sarah Oliai’s practice focuses on helping companies navigate complex regulatory issues regarding international trade and national security. Specifically, Sarah advises clients on issues relating to the Export Administration Regulations (EAR), the International Traffic in Arms Regulations (ITAR), economic sanctions programs administered by the Office of Foreign Assets Control (OFAC), and the Committee on Foreign Investment in the US.
Senti Biosciences Sells Certain Assets to Celadon Partners
August 14, 2023
Cooley advised Senti Biosciences, a biotechnology company, on its sale of certain assets – including its manufacturing facility and chemistry, manufacturing, and controls capabilities – to Celadon Partners.
Cooley advised ColdQuanta, a global quantum technology company, on its $110 million Series B financing round. The company will use the capital to commercialize its product portfolio to include quantum computing, quantum algorithms and applications, atomic clocks, sensors and components. Partner Mike Nelson led the Cooley team advising ColdQuanta.
Cooley represented Genomatica, a sustainability leader in the commercialization and expansion of sustainable materials, in its $118 million Series C funding led by Novo Holdings. Partner Tom Coll led the Cooley team.
Cooley advised Stori, a rapidly growing fintech company offering credit card products to Mexico’s underserved population, on its latest financing round of $150 million, which values the company at $1.2 billion. Stori now joins the ranks of the few Mexican startups that have reached unicorn status. Lawyers Mike Lincoln, Eddie Sniezek and Jennifer Don led the Cooley team advising Stori.
Cooley advised Cribl, a leader in enabling open observability for technology professionals, on its $150 million Series D financing round. Partner Craig Jacoby led the Cooley team advising Cribl.
